0016-3813 0016-3813 S0016-38132020000700001 10.24875/gmm.m20000347 México México México México México México México México 00 00 2020 00 00 2020 156 1 14

1 European Generic Medicines Association 2011 2 2014 3 2017 44 1 1 3-12 4 2015 106 7 7 545-9 5 2009 2 4 4 232-3 6 2017 13 127-38 7 Listado de medicamentos biotecnológicos biocomparables 8 Mexican guidelines for biocomparables [Internet] 9 American Academy of Dermatology Position statement on generic therapeutic &biosimilar substitution [Internet] 2013 10 2015 106 4 4 249-51 11 2016 29 9 9 574-77 12 Canadian Association of Psoriasis Patients Our position on biosimilars:additional considerations, 2014 [Internet] 13 National Psoriasis Foundation Mediacal Board Biosimilar substitution [Internet] 14 2017 177 1495-502 15 2013 9 2 2 113-6 16 2015 55 S123-32 17 Draft Guidance for Industry Considerations in demonstrating interchangeability with a reference product [Internet] 18 Ficha técnica Amgevita™[Internet] 19 Ficha técnica Hyrimoz®[Internet] 20 Ficha técnica Hulio®[Internet] 21 2018 179 3 3 623-31 22 2018 12 suppl 1 suppl 1 S442 23 2018 12 suppl1 suppl1 S357 24 2017 76 6 6 1093-102 25 2017 177 6 6 1562-74 26 2016 74 5,Suppl 1 5,Suppl 1 AB275 27 2018 76 Suppl 2 Suppl 2 144 28 29 2017 83 7 7 1405-15 30 Ficha técnica Benepali®[Internet] 31 Ficha técnica de Brenzys®[Internet] 32 Ficha técnica de Eticovo®[Internet] 33 Información Infinitam®[Internet] 34 2019 180 2 2 409-10 35 2018 32 3 3 420-7 36 2017 176 4 4 928-38 37 2017 69 suppl 10 suppl 10 38 39 Ficha técnica de Remsima®[Internet] 40 2018 179 2 2 371-80 41 2017 389 10086 10086 2304-16 42 2017 76 Suppl 2 Suppl 2 472 43 2017 177 6 6 e348 44 2017 177 6 6 e326 45 2016 75 4 4 736-9 46 2018 178 2 2 509-19 47